메뉴 건너뛰기




Volumn 134, Issue 1, 2001, Pages 72-74

Obesity and hypertension: What should we do?

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTIOBESITY AGENT; FENFLURAMINE; TETRAHYDROLIPSTATIN;

EID: 0035793145     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-134-1-200101020-00016     Document Type: Review
Times cited : (4)

References (16)
  • 1
    • 0030713021 scopus 로고    scopus 로고
    • The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure
    • PMID: 0009385294
    • (1997) Arch Intern Med , vol.157 , pp. 2413-2446
  • 6
    • 1842365433 scopus 로고    scopus 로고
    • Effects of weight loss and sodium reduction intervention on blood pressure and hypertension incidence in overweight people with high-normal blood pressure. The Trials of Hypertension Prevention, phase II
    • The Trials of Hypertension Prevention Collaborative Research Group. PMID: 0009080920
    • (1997) Arch Intern Med , vol.157 , pp. 657-667
  • 10
    • 0032490150 scopus 로고    scopus 로고
    • Effects of sodium restriction on blood pressure, renin, aldosterone, catecholamines, cholesterols, and triglyceride: A meta-analysis
    • PMID: 0009582047
    • (1998) JAMA , vol.279 , pp. 1383-1391
    • Graudal, N.A.1    Galloe, A.M.2    Garred, P.3
  • 16
    • 0033585502 scopus 로고    scopus 로고
    • Pharmacotherapy for obesity
    • PMID: 0009918485
    • (1999) JAMA , vol.281 , pp. 278-280
    • Williamson, D.F.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.